FECTOVIR
LIVE

Serial Number

79281592

Owner

POLYPLUS TRANSFECTION

Attorney

Pina Campagna

Filing Date

Feb 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

FECTOVIR Trademark

Serial Number: 79281592 • Registration: 6366650

FECTOVIR is a trademark filed by POLYPLUS TRANSFECTION on February 5, 2020. The trademark is classified under Class 1 (Chemicals). The application is currently registered and active.

Owner Contact Info

POLYPLUS TRANSFECTION (23 trademarks)

75 rue Marguerite Perey

Entity Type: 99

Sartorius Polyplus (14 trademarks)

75 rue Marguerite Perey

Entity Type: 98

Trademark Details

Filing Date

February 5, 2020

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Goods & Services

Chemical and biochemical products for scientific use and for research, namely, chemical preparations for scientific purposes, amino acids for laboratory or research use, diagnostic reagents for scientific or research use; chemical and biochemical products for scientific use and for research, namely, chemical preparations for scientific purposes, amino acids for laboratory or research use, diagnostic reagents for scientific or research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles; preparations, agents and reagents for scientific use and for research, namely, chemical preparations for scientific purposes, amino acids for laboratory or research use, diagnostic reagents for scientific or research use, for genetic diagnosis; chemical or biochemical transfection test kits for virus manufacturing for scientific use and for research containing preparations, agents and reagents; chemical or biochemical test kits for scientific use or for research containing preparations, agents and reagents in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 1, 2026 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 1, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 30, 2025 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 31, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 29, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 1, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 14, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2021 CRFA
ASSIGNED TO LIE
Feb 4, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 30, 2020 TROA
REFUSAL PROCESSED BY IB
May 23, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 6, 2020 RFCS
REFUSAL PROCESSED BY MPU
May 6, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 3, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 30, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 26, 2020 REPR